We all know that IV adrenaline (along with CPR) is standard of care for patients in cardiac arrest with non-shockable rhythms. But… did you know there really hasn't been any well controlled trials to see if it really makes a difference in endpoints such as improved survival and neurologically intact survival outcomes? M.W. Donnino and his team in Boston have just published a study that shows it just might.Read More
Well, I’ve been hearing a variety of comments thrown around about the optimum management of STEMIs. So, in the spirit of reviewing the basics on this important topic, let’s review the key papers that compare PCI to thrombolytic therapy for AMI.Read More
How are you rate-controlling your a-fibers these days? Everyone has their own concoction, but since we now stock IV diltiazem (which is a first line treatment that most of us Yanks learned), we thought we might share a recent publication in Critical Care Medicine with you.
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation.Read More